Chapter 1. PSORIASIS DRUGS MARKET- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. PSORIASIS DRUGS MARKET- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. PSORIASIS DRUGS MARKET- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. PSORIASIS DRUGS MARKET- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4     Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5. PSORIASIS DRUGS MARKET- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. PSORIASIS DRUGS MARKET- By Type of Treatment
6.1    Biologic Drugs
6.2    Small Molecule Systemic Drugs
6.3    Tropical Therapies
Chapter 7. PSORIASIS DRUGS MARKET- By Mechanism of Action
7.1    TNF Alpha Inhibitors
          7.1.1    Etanercept
          7.1.2    Certolizumab Pegol
          7.1.3    Adalimumab
          7.1.4    Infiximab
          7.1.5    Golimumab
7.2    PDE4 Inhibitors
          7.2.1    Apremilast
7.3    Interleukin Inhibitors
          7.3.1    Secukinumab
          7.3.2    Ustekinumab
          7.3.3    Other Interleukin Inhibitors
7.4    Other Mechanisms of Action
Chapter 8. PSORIASIS DRUGS MARKET- By Route of Administration
8.1    Oral
8.2    Parenteral
8.3    Topical 
Chapter 9. PSORIASIS DRUGS MARKET– By Region
9.1    North America
9.2    Europe
9.3    Asia-Pacific
9.4    Latin America
9.5    The Middle East
9.6    Africa
Chapter 10. PSORIASIS DRUGS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1    Company 1
10.2    Company 2
10.3    Company 3
10.4    Company 4
10.5    Company 5
10.6    Company 6
10.7    Company 7
10.8    Company 8
10.9    Company 9
10.10    Company 10
 

Download Sample